Doppler ultrasound cannot diagnose cerebral clots:
This article was originally published in Clinica
Executive Summary
Doppler ultrasound cannot be used to rule out a diagnosis of cerebral venous thrombosis, although it is useful for monitoring patients with the condition, says Dr Jose Valdueza of Humboldt University in Berlin, Germany. Together with colleagues, Dr Valdueza used serial transcranial Doppler ultrasound to examine 18 patients diagnosed with cerebral venous thrombosis. With treatment, the high peak blood flow velocities that indicate disease severity decreased, the researchers found. But the technique cannot replace angiography or MRI for diagnosis, they report in Archives of Neurology (February).
You may also be interested in...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.